NCT03058757View on ClinicalTrials.gov

The Effectiveness and Safety of Neoadjuvant Intravesical Mitomycin-C Instillation

PHASE2CompletedINTERVENTIONAL
Enrollment

71

Participants

Timeline

Start Date

February 1, 2017

Primary Completion Date

February 18, 2021

Study Completion Date

December 31, 2022

Conditions
Bladder Cancer
Interventions
DRUG

intravesical mitomycin-C 40mg/20ml instillation

"neoadjuvant Intravesical mitomycin-C 40mg/20ml instillation~* one day before surgery~* four hours before surgery"

Trial Locations (1)

Unknown

National Cancer Center, Goyang

All Listed Sponsors
lead

National Cancer Center, Korea

OTHER_GOV

NCT03058757 - The Effectiveness and Safety of Neoadjuvant Intravesical Mitomycin-C Instillation | Biotech Hunter | Biotech Hunter